Current Drug Targets
Title: Editorial [ Hot Topic: Targets for Development of Drugs Against Orphan Diseases (Guest Editor: Walter Filgueira de Azevedo Jr.) ]
Volume: 8 Issue: 3
Author(s): Walter Filgueira de Azevedo
Affiliation:
Export Options
About this article
Cite this article as:
Filgueira de Azevedo Walter, Editorial [ Hot Topic: Targets for Development of Drugs Against Orphan Diseases (Guest Editor: Walter Filgueira de Azevedo Jr.) ], Current Drug Targets 2007; 8 (3) . https://dx.doi.org/10.2174/138945007780058960
DOI https://dx.doi.org/10.2174/138945007780058960 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research
CNS & Neurological Disorders - Drug Targets NMR Based Metabolomics: An Exquisite and Facile Method for Evaluating Therapeutic Efficacy and Screening Drug Toxicity
Current Topics in Medicinal Chemistry Green Formation of Novel Pyridinyltriazole-Salicylidene Schiff Bases
Current Organic Synthesis New Bioactive Metabolites from the Marine-derived Fungi Aspergillus
Mini-Reviews in Medicinal Chemistry Novel Adjunctive Therapies for the Treatment of Tuberculosis
Current Molecular Medicine Hepatitis C Viruss Immune Evasion Strategies
Current Immunology Reviews (Discontinued) In Vivo Induced Antigen Technology (IVIAT) and Change Mediated Antigen Technology (CMAT)
Infectious Disorders - Drug Targets Adenovirus-based Immunotherapy for Prostate Cancer
Current Cancer Therapy Reviews Synthesis of Cross-linkable 2,5-Diketopiperazine Derivatives
Letters in Organic Chemistry Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews Challenges Associated with Current and Future TB Treatment
Infectious Disorders - Drug Targets New Approaches to Tuberculosis - Novel Drugs Based on Drug Targets Related to Toll-Like Receptors in Macrophages
Current Pharmaceutical Design Editorial [Hot Topic: Tuberculosis; Opportunities for Treatment Optimization (Executive Guest Editor: Jan-Willem C. Alffenaar)]
Current Pharmaceutical Design Review of Structures Containing Fullerene-C60 for Delivery of Antibacterial Agents. Multitasking model for Computational Assessment of Safety Profiles
Current Bioinformatics Inhibitory MHC Class I Receptors on Myeloid Cells
Current Immunology Reviews (Discontinued) Synthesis and Assessment of 3-Substituted Phenazines as Novel Antichlamydial Agents
Medicinal Chemistry Influence of Leptin on Immunity
Current Immunology Reviews (Discontinued) Pharmacogenomics – Implications in the Development of HIV-Associated Brain Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Ototoxicity: Mechanisms of Cochlear Impairment and its Prevention
Current Medicinal Chemistry Environmental Exposure, and Other Behavioral Risk Factors in Breast Cancer
Current Cancer Therapy Reviews